In an oral presentation, Lilly will share patient-reported outcomes (PROs) from the Phase 3 EMBER-3 trial in patients with estrogen receptor positive (ER+), human epidermal growth factor receptor ...

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

A Phase 1/2 clinical study of PD-1/IL-2 α-bia s bispecific antibody fusion protein (IBI363) in the treatment of advanced "cold" tumor subtypes (acral and mucosal) malignant melanoma The data presented ...

Across four clinical trials in 3691 patients, diarrhea occurred in 81 to 90% of patients who received Verzenio. Grade 3 diarrhea occurred in 8 to 20% of patients receiving Verzenio. Most patients ...

May 09, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform ... announced oral and poster presentations highlighting ...

CLINICAL BENEFIT, INCLUDING CAFS AND SURVIVAL, IS GREATEST IN A SUBGROUP OF ALS PATIENTS THAT SERVES AS THE BASIS FOR THE RECENTLY AUTHORIZED PHASE 3 CONFIRMATORY STUDY AB Science SA (Euronext ...

RADA, a world-famous acting school, has trained Anthony Hopkins, Alan Rickman and Phoebe Waller-Bridge. Add to that list Boss Class host Andrew Palmer. In this episode, he gets tips on how to be a ...

reported data from two clinical presentations at EASL, including rapid and profound anti-HBV responses, and favorable safety and tolerability results, from the first-ever combination therapy with ...